1 Approved COVID-19 Vaccines Market Overview
1.1 Product Overview and Scope of Approved COVID-19 Vaccines
1.2 Approved COVID-19 Vaccines Segment by Type
1.2.1 Global Approved COVID-19 Vaccines Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Component Viral Vaccines
1.2.3 Whole Virus Vaccines
1.3 Approved COVID-19 Vaccines Segment by Application
1.3.1 Global Approved COVID-19 Vaccines Sales Comparison by Application: (2022-2028)
1.3.2 Adults
1.3.3 Children
1.3.4 Elderly
1.4 Global Approved COVID-19 Vaccines Market Size Estimates and Forecasts
1.4.1 Global Approved COVID-19 Vaccines Revenue 2017-2028
1.4.2 Global Approved COVID-19 Vaccines Sales 2017-2028
1.4.3 Approved COVID-19 Vaccines Market Size by Region: 2017 Versus 2021 Versus 2028
2 Approved COVID-19 Vaccines Market Competition by Manufacturers
2.1 Global Approved COVID-19 Vaccines Sales Market Share by Manufacturers (2017-2022)
2.2 Global Approved COVID-19 Vaccines Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Approved COVID-19 Vaccines Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Approved COVID-19 Vaccines Manufacturing Sites, Area Served, Product Type
2.5 Approved COVID-19 Vaccines Market Competitive Situation and Trends
2.5.1 Approved COVID-19 Vaccines Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Approved COVID-19 Vaccines Players Market Share by Revenue
2.5.3 Global Approved COVID-19 Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Approved COVID-19 Vaccines Retrospective Market Scenario by Region
3.1 Global Approved COVID-19 Vaccines Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Approved COVID-19 Vaccines Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Approved COVID-19 Vaccines Market Facts & Figures by Country
3.3.1 North America Approved COVID-19 Vaccines Sales by Country
3.3.2 North America Approved COVID-19 Vaccines Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Approved COVID-19 Vaccines Market Facts & Figures by Country
3.4.1 Europe Approved COVID-19 Vaccines Sales by Country
3.4.2 Europe Approved COVID-19 Vaccines Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Approved COVID-19 Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific Approved COVID-19 Vaccines Sales by Region
3.5.2 Asia Pacific Approved COVID-19 Vaccines Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Approved COVID-19 Vaccines Market Facts & Figures by Country
3.6.1 Latin America Approved COVID-19 Vaccines Sales by Country
3.6.2 Latin America Approved COVID-19 Vaccines Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Approved COVID-19 Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa Approved COVID-19 Vaccines Sales by Country
3.7.2 Middle East and Africa Approved COVID-19 Vaccines Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Approved COVID-19 Vaccines Historic Market Analysis by Type
4.1 Global Approved COVID-19 Vaccines Sales Market Share by Type (2017-2022)
4.2 Global Approved COVID-19 Vaccines Revenue Market Share by Type (2017-2022)
4.3 Global Approved COVID-19 Vaccines Price by Type (2017-2022)
5 Global Approved COVID-19 Vaccines Historic Market Analysis by Application
5.1 Global Approved COVID-19 Vaccines Sales Market Share by Application (2017-2022)
5.2 Global Approved COVID-19 Vaccines Revenue Market Share by Application (2017-2022)
5.3 Global Approved COVID-19 Vaccines Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Moderna
6.1.1 Moderna Corporation Information
6.1.2 Moderna Description and Business Overview
6.1.3 Moderna Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Moderna Approved COVID-19 Vaccines Product Portfolio
6.1.5 Moderna Recent Developments/Updates
6.2 CanSino Biologicals
6.2.1 CanSino Biologicals Corporation Information
6.2.2 CanSino Biologicals Description and Business Overview
6.2.3 CanSino Biologicals Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.2.4 CanSino Biologicals Approved COVID-19 Vaccines Product Portfolio
6.2.5 CanSino Biologicals Recent Developments/Updates
6.3 Inovio Pharmaceuticals
6.3.1 Inovio Pharmaceuticals Corporation Information
6.3.2 Inovio Pharmaceuticals Description and Business Overview
6.3.3 Inovio Pharmaceuticals Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Inovio Pharmaceuticals Approved COVID-19 Vaccines Product Portfolio
6.3.5 Inovio Pharmaceuticals Recent Developments/Updates
6.4 Shenzhen Geno-Immune Medical Institute
6.4.1 Shenzhen Geno-Immune Medical Institute Corporation Information
6.4.2 Shenzhen Geno-Immune Medical Institute Description and Business Overview
6.4.3 Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Product Portfolio
6.4.5 Shenzhen Geno-Immune Medical Institute Recent Developments/Updates
6.5 GlaxoSmithKine
6.5.1 GlaxoSmithKine Corporation Information
6.5.2 GlaxoSmithKine Description and Business Overview
6.5.3 GlaxoSmithKine Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.5.4 GlaxoSmithKine Approved COVID-19 Vaccines Product Portfolio
6.5.5 GlaxoSmithKine Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Pfizer Approved COVID-19 Vaccines Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Johnson?Johnson
6.6.1 Johnson?Johnson Corporation Information
6.6.2 Johnson?Johnson Description and Business Overview
6.6.3 Johnson?Johnson Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Johnson?Johnson Approved COVID-19 Vaccines Product Portfolio
6.7.5 Johnson?Johnson Recent Developments/Updates
6.8 Heat Biologics
6.8.1 Heat Biologics Corporation Information
6.8.2 Heat Biologics Description and Business Overview
6.8.3 Heat Biologics Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Heat Biologics Approved COVID-19 Vaccines Product Portfolio
6.8.5 Heat Biologics Recent Developments/Updates
6.9 Sanofi
6.9.1 Sanofi Corporation Information
6.9.2 Sanofi Description and Business Overview
6.9.3 Sanofi Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Sanofi Approved COVID-19 Vaccines Product Portfolio
6.9.5 Sanofi Recent Developments/Updates
7 Approved COVID-19 Vaccines Manufacturing Cost Analysis
7.1 Approved COVID-19 Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Approved COVID-19 Vaccines
7.4 Approved COVID-19 Vaccines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Approved COVID-19 Vaccines Distributors List
8.3 Approved COVID-19 Vaccines Customers
9 Approved COVID-19 Vaccines Market Dynamics
9.1 Approved COVID-19 Vaccines Industry Trends
9.2 Approved COVID-19 Vaccines Market Drivers
9.3 Approved COVID-19 Vaccines Market Challenges
9.4 Approved COVID-19 Vaccines Market Restraints
10 Global Market Forecast
10.1 Approved COVID-19 Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Approved COVID-19 Vaccines by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Approved COVID-19 Vaccines by Type (2023-2028)
10.2 Approved COVID-19 Vaccines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Approved COVID-19 Vaccines by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Approved COVID-19 Vaccines by Application (2023-2028)
10.3 Approved COVID-19 Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Approved COVID-19 Vaccines by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Approved COVID-19 Vaccines by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
